Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China · Delayed Price · Currency is CNY 110.00
+3.34 (3.13%)
Sep 30, 2026, 3:00 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 29.12 billion as of October 2, 2026. Its market cap has increased by 1.64% in one year.
Market Cap
29.12B
Enterprise Value
27.46B
Revenue
1.64B
Ranking
n/a
PE Ratio
53.02
Stock Price
110.00
ChartMarket Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 29.12B, an increase of 62.66%. That is a compound annual growth rate of 7.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 29.12B | 18.66% |
| Dec 31, 2025 | 24.54B | 48.77% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunshine Guojian Pharmaceutical (Shanghai) | 37.13B |
| Shanghai RAAS Blood Products | 35.07B |
| Beijing Wantai Biological Pharmacy Enterprise | 34.57B |
| Chongqing Zhifei Biological Products | 33.47B |
| Beijing Tiantan Biological Products | 24.90B |
| Hualan Biological Engineering | 24.35B |
| Acrobiosystems | 23.58B |
| Evopoint Biosciences | 21.51B |